RECURRENT MULTIPLE MYELOMA
Clinical trials for RECURRENT MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo for tough myeloma shows early promise but study ends early
Disease control TerminatedThis early-phase trial tested a new drug (CB-839 HCl) combined with two standard treatments (carfilzomib and dexamethasone) in 19 adults with multiple myeloma that had come back or stopped responding to prior therapy. The goal was to find the safest dose and check for side effect…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:50 UTC
-
New combo therapy for tough myeloma cases shows early promise but study halted
Disease control TerminatedThis early-phase study tested a new drug (KRT-232) combined with three standard myeloma treatments in 35 patients whose cancer had come back or stopped responding. The goal was to find the safest dose and check for side effects. The study was terminated early, so results are limi…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:31 UTC